Background. Inodilators are commonly used in critically ill patients, but their effect on survival has not been properly studied to date. The objective of this work was to conduct a network meta-analysis on the effects of inodilators on survival in adult cardiac surgery patients, and to compare and rank drugs that have not been adequately compared in head-to-head trials. Methods. Relevant studies were independently searched in BioMedCentral, MEDLINE/PubMed, Embase, and the Cochrane Central Register of clinical trials (updated on May 1, 2014). The criteria for inclusion were: random allocation to treatment with at least one group receiving dobutamine, enoximone, levosimendan, or milrinone and at least another group receiving the above inoditators or placebo, performed in cardiac surgical patients. The endpoint was to identify differences in mortality at longest follow-up available. Results. The 46 included trials were published between 1995 and 2014 and randomised 2647 patients. The Bayesian network meta-analysis found that only the use of levosimendan was associated with a decrease in mortality when compared with placebo (posterior mean of OR=0.48, 95% CrI 0.28 to 0.80). The posterior distribution of the probability for each inoditator to be the best and the worst drug showed that levosimendan is the best agent to improve survival after cardiac surgery. The sensitivity analyses performed did not produce different interpretative result. Conclusion. Levosimendan seems to be the most efficacious inoditator to improve survival in cardiac surgery.

A Bayesian network meta-analysis on the effect of inodilatory agents on mortality / Greco, T.; Calabrò, M. G.; Covello, R. D.; Greco, M.; Pasin, L.; Morelli, A.; Landoni, G.; Zangrillo, A.. - In: BRITISH JOURNAL OF ANAESTHESIA. - ISSN 0007-0912. - STAMPA. - 114:5(2015), pp. 746-756. [10.1093/bja/aeu446]

A Bayesian network meta-analysis on the effect of inodilatory agents on mortality

Morelli, A.;
2015

Abstract

Background. Inodilators are commonly used in critically ill patients, but their effect on survival has not been properly studied to date. The objective of this work was to conduct a network meta-analysis on the effects of inodilators on survival in adult cardiac surgery patients, and to compare and rank drugs that have not been adequately compared in head-to-head trials. Methods. Relevant studies were independently searched in BioMedCentral, MEDLINE/PubMed, Embase, and the Cochrane Central Register of clinical trials (updated on May 1, 2014). The criteria for inclusion were: random allocation to treatment with at least one group receiving dobutamine, enoximone, levosimendan, or milrinone and at least another group receiving the above inoditators or placebo, performed in cardiac surgical patients. The endpoint was to identify differences in mortality at longest follow-up available. Results. The 46 included trials were published between 1995 and 2014 and randomised 2647 patients. The Bayesian network meta-analysis found that only the use of levosimendan was associated with a decrease in mortality when compared with placebo (posterior mean of OR=0.48, 95% CrI 0.28 to 0.80). The posterior distribution of the probability for each inoditator to be the best and the worst drug showed that levosimendan is the best agent to improve survival after cardiac surgery. The sensitivity analyses performed did not produce different interpretative result. Conclusion. Levosimendan seems to be the most efficacious inoditator to improve survival in cardiac surgery.
2015
anaesthesia - meta-analysis; anaesthetics i.v.; cardiovascularanaesthesia; surgery - cardiovascular; bayes theorem; cardiac surgical procedures; critical illness; dobutamine; enoximone; humans; hydrazones; milrinone; pyridazines; vasodilator agents; anesthesiology and pain medicine
01 Pubblicazione su rivista::01a Articolo in rivista
A Bayesian network meta-analysis on the effect of inodilatory agents on mortality / Greco, T.; Calabrò, M. G.; Covello, R. D.; Greco, M.; Pasin, L.; Morelli, A.; Landoni, G.; Zangrillo, A.. - In: BRITISH JOURNAL OF ANAESTHESIA. - ISSN 0007-0912. - STAMPA. - 114:5(2015), pp. 746-756. [10.1093/bja/aeu446]
File allegati a questo prodotto
File Dimensione Formato  
Greco_Bayesian_2015.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 254.42 kB
Formato Adobe PDF
254.42 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1087954
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 47
social impact